Absorption, Bioavailability, and Immunogenicity after Subcutaneous Administration: Evaluation of a Subcutaneous Platform within the Open Systems Pharmacology framework

PAGE 32 (2024) Abstr 11022
Pellowe M, Selvaggio G, Benamara S, Dubbelboer I, Teutonico D, Chenel M, Sjögren E.
ConferencePBPK/PBBMProgram strategies and efficienciesQSP

Pharmetheus Affiliates

Portrait-of-Moriah-Pellowe_Pharmetheus
Director, MIDD Consultant

Moriah Pellowe

See bio
Portrait-of-Gianluca-Selvaggio-Pharmetheus
Director, MIDD Consultant

Gianluca Selvaggio

See bio
Portrait-of-Marylore-Chenel_Pharmetheus
Chief Research Officer

Marylore Chenel

See bio
Portrait-of-Erik-Sjogren_Pharmetheus-2
Principal Director, PBPK & PBBM Scientific Lead

Erik Sjögren

See bio